Spironolactone and enalapril differentially up-regulate the expression of VEGF and heme oxygenase-1 in the neonatal rat kidney

Hyung-Eun Yim, Ji Hae Kim, Kee Hwan Yoo, In Sun Bae, Young Sook Hong, Joo Won Lee

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Both the renin-angiotensin-aldosterone system (RAAS) and hypoxia are vital physiological factors involved in the control of nephrogenesis and vascularization. We investigated the relationship between RAAS and hypoxia in the developing kidney. The expression of VEGF and heme oxygenase (HO)-1 related with the oxygen was analyzed in the enalapril-or spironolactone-treated neonatal rat kidneys. Enalapril (30 mg/kg/d) or spironolactone (200 mg/kg/d) was administered to newborn rat pups for 7 d. The newborn rats were injected i.p. with pimonidazole (200 mg/kg), a marker of severe tissue hypoxia, 1 h before killing. VEGF and HO-1 protein expression was significantly increased by immunoblots and immunohistochemistry in both the enalapril-and spironolactone-treated kidneys, compared with the controls (p < 0.05). HO-1 mRNA expression was increased in the spironolactone-treated group (p < 0.05). The immunoactivity of pimonidazole was not different from that of the controls in the enalapril-treated group, whereas it was increased in the spironolactone-treated group. The results of this study indicate that aldosterone blockade or angiotensin II inhibition in the developing rat kidney up-regulated renal VEGF and HO-1 expression regardless of the hypoxic conditions and may differentially modulate VEGF and HO-1 production.

Original languageEnglish
Pages (from-to)378-383
Number of pages6
JournalPediatric Research
Volume69
Issue number5 PART 1
DOIs
Publication statusPublished - 2011 May 1

Fingerprint

Spironolactone
Heme Oxygenase-1
Enalapril
Vascular Endothelial Growth Factor A
Up-Regulation
Kidney
Renin-Angiotensin System
Aldosterone
Angiotensin II
Immunohistochemistry
Oxygen
Messenger RNA
Hypoxia
Proteins

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Spironolactone and enalapril differentially up-regulate the expression of VEGF and heme oxygenase-1 in the neonatal rat kidney. / Yim, Hyung-Eun; Kim, Ji Hae; Yoo, Kee Hwan; Bae, In Sun; Hong, Young Sook; Lee, Joo Won.

In: Pediatric Research, Vol. 69, No. 5 PART 1, 01.05.2011, p. 378-383.

Research output: Contribution to journalArticle

Yim, Hyung-Eun ; Kim, Ji Hae ; Yoo, Kee Hwan ; Bae, In Sun ; Hong, Young Sook ; Lee, Joo Won. / Spironolactone and enalapril differentially up-regulate the expression of VEGF and heme oxygenase-1 in the neonatal rat kidney. In: Pediatric Research. 2011 ; Vol. 69, No. 5 PART 1. pp. 378-383.
@article{0f213b7b27f54324846bbe719ea86639,
title = "Spironolactone and enalapril differentially up-regulate the expression of VEGF and heme oxygenase-1 in the neonatal rat kidney",
abstract = "Both the renin-angiotensin-aldosterone system (RAAS) and hypoxia are vital physiological factors involved in the control of nephrogenesis and vascularization. We investigated the relationship between RAAS and hypoxia in the developing kidney. The expression of VEGF and heme oxygenase (HO)-1 related with the oxygen was analyzed in the enalapril-or spironolactone-treated neonatal rat kidneys. Enalapril (30 mg/kg/d) or spironolactone (200 mg/kg/d) was administered to newborn rat pups for 7 d. The newborn rats were injected i.p. with pimonidazole (200 mg/kg), a marker of severe tissue hypoxia, 1 h before killing. VEGF and HO-1 protein expression was significantly increased by immunoblots and immunohistochemistry in both the enalapril-and spironolactone-treated kidneys, compared with the controls (p < 0.05). HO-1 mRNA expression was increased in the spironolactone-treated group (p < 0.05). The immunoactivity of pimonidazole was not different from that of the controls in the enalapril-treated group, whereas it was increased in the spironolactone-treated group. The results of this study indicate that aldosterone blockade or angiotensin II inhibition in the developing rat kidney up-regulated renal VEGF and HO-1 expression regardless of the hypoxic conditions and may differentially modulate VEGF and HO-1 production.",
author = "Hyung-Eun Yim and Kim, {Ji Hae} and Yoo, {Kee Hwan} and Bae, {In Sun} and Hong, {Young Sook} and Lee, {Joo Won}",
year = "2011",
month = "5",
day = "1",
doi = "10.1203/PDR.0b013e3182114c38",
language = "English",
volume = "69",
pages = "378--383",
journal = "Pediatric Research",
issn = "0031-3998",
publisher = "Lippincott Williams and Wilkins",
number = "5 PART 1",

}

TY - JOUR

T1 - Spironolactone and enalapril differentially up-regulate the expression of VEGF and heme oxygenase-1 in the neonatal rat kidney

AU - Yim, Hyung-Eun

AU - Kim, Ji Hae

AU - Yoo, Kee Hwan

AU - Bae, In Sun

AU - Hong, Young Sook

AU - Lee, Joo Won

PY - 2011/5/1

Y1 - 2011/5/1

N2 - Both the renin-angiotensin-aldosterone system (RAAS) and hypoxia are vital physiological factors involved in the control of nephrogenesis and vascularization. We investigated the relationship between RAAS and hypoxia in the developing kidney. The expression of VEGF and heme oxygenase (HO)-1 related with the oxygen was analyzed in the enalapril-or spironolactone-treated neonatal rat kidneys. Enalapril (30 mg/kg/d) or spironolactone (200 mg/kg/d) was administered to newborn rat pups for 7 d. The newborn rats were injected i.p. with pimonidazole (200 mg/kg), a marker of severe tissue hypoxia, 1 h before killing. VEGF and HO-1 protein expression was significantly increased by immunoblots and immunohistochemistry in both the enalapril-and spironolactone-treated kidneys, compared with the controls (p < 0.05). HO-1 mRNA expression was increased in the spironolactone-treated group (p < 0.05). The immunoactivity of pimonidazole was not different from that of the controls in the enalapril-treated group, whereas it was increased in the spironolactone-treated group. The results of this study indicate that aldosterone blockade or angiotensin II inhibition in the developing rat kidney up-regulated renal VEGF and HO-1 expression regardless of the hypoxic conditions and may differentially modulate VEGF and HO-1 production.

AB - Both the renin-angiotensin-aldosterone system (RAAS) and hypoxia are vital physiological factors involved in the control of nephrogenesis and vascularization. We investigated the relationship between RAAS and hypoxia in the developing kidney. The expression of VEGF and heme oxygenase (HO)-1 related with the oxygen was analyzed in the enalapril-or spironolactone-treated neonatal rat kidneys. Enalapril (30 mg/kg/d) or spironolactone (200 mg/kg/d) was administered to newborn rat pups for 7 d. The newborn rats were injected i.p. with pimonidazole (200 mg/kg), a marker of severe tissue hypoxia, 1 h before killing. VEGF and HO-1 protein expression was significantly increased by immunoblots and immunohistochemistry in both the enalapril-and spironolactone-treated kidneys, compared with the controls (p < 0.05). HO-1 mRNA expression was increased in the spironolactone-treated group (p < 0.05). The immunoactivity of pimonidazole was not different from that of the controls in the enalapril-treated group, whereas it was increased in the spironolactone-treated group. The results of this study indicate that aldosterone blockade or angiotensin II inhibition in the developing rat kidney up-regulated renal VEGF and HO-1 expression regardless of the hypoxic conditions and may differentially modulate VEGF and HO-1 production.

UR - http://www.scopus.com/inward/record.url?scp=79954577318&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79954577318&partnerID=8YFLogxK

U2 - 10.1203/PDR.0b013e3182114c38

DO - 10.1203/PDR.0b013e3182114c38

M3 - Article

VL - 69

SP - 378

EP - 383

JO - Pediatric Research

JF - Pediatric Research

SN - 0031-3998

IS - 5 PART 1

ER -